| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.853 | 35.320 | 39.339 | 46.168 | 56.786 | 63.644 | 66.683 | 66.646 | 27.076 | 1.166 |
| Total Income - EUR | 35.104 | 35.410 | 39.390 | 46.291 | 56.925 | 63.820 | 66.805 | 67.069 | 28.464 | 1.399 |
| Total Expenses - EUR | 13.243 | 15.256 | 11.785 | 12.720 | 13.949 | 15.070 | 16.389 | 18.734 | 9.001 | 784 |
| Gross Profit/Loss - EUR | 21.861 | 20.155 | 27.605 | 33.570 | 42.976 | 48.750 | 50.416 | 48.335 | 19.463 | 615 |
| Net Profit/Loss - EUR | 20.808 | 19.800 | 27.165 | 33.107 | 42.407 | 48.123 | 49.748 | 47.664 | 17.392 | 512 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 0 |
Check the financial reports for the company - Phylaxis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 1.921 | 1.396 | 886 | 395 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 26.434 | 23.666 | 30.595 | 37.306 | 47.501 | 53.516 | 55.321 | 53.309 | 20.965 | 3.995 |
| Inventories | 0 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.278 | 0 | 2.563 | 3.691 | 4.531 | 4.772 | 4.758 | 5.539 | 364 | 0 |
| Cash | 24.156 | 23.651 | 28.032 | 33.614 | 42.970 | 48.744 | 50.563 | 47.770 | 20.601 | 3.995 |
| Shareholders Funds | 3.871 | 23.632 | 30.931 | 36.805 | 46.033 | 51.680 | 53.226 | 51.153 | 20.870 | 3.971 |
| Social Capital | 1.575 | 1.559 | 1.532 | 1.504 | 1.475 | 1.447 | 1.415 | 1.419 | 1.415 | 1.407 |
| Debts | 22.564 | 1.955 | 1.059 | 1.388 | 1.863 | 1.836 | 2.095 | 2.156 | 95 | 24 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Phylaxis S.r.l.